bpc-157 ind fda status The honest truth About Peptides BP-157 and TB 500! Before you start #peptides, watch this video! BPC-157 Before the FDA: Briefing

TB-500 (Thymosin Beta-4) Not FDA-approved as a finished drug product, though clinical trials have used IV thymosin beta-4

Your workspace should be clean, dry, and free from drafts or movement that could introduce bacteria

HYGIENE A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS A61P25/00Drugs for disorders of the nervous system AHUMAN NECESSITIES A61MEDICAL OR VETERINARY SCIENCE

Once a vial is reconstituted and the dose is drawn into the syringe, the location and technique of the injection determine whether the material is delivered into the intended tissue layer, how comfortable the process is, and whether the skin at the injection site stays healthy over a multi-week protocol

4 u 0.04 mL 4 u 0.04 mL 8 u 0.08 mL Reconstitute each peptide in its own vial never add water to multiple peptides in one vial